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A large cohort of 74,828 benzene-exposed and 35,805 nonexposed workers employed between
1972 and 1987 in 12 cities in China was followed to determine mortality from all causes. Benzene-
exposed study subjects were employed in a variety of occupations including coating applications,
and rubber, chemical, and shoe production. Mortality was slightly increased among workers with
greater cumulative exposure to benzene (Ptrend <0.05), but this excess was largely due to cancer
deaths (Ptrend <0.01). Deaths due to lymphatic and hematopoietic malignancies (Ptrend = 0.01)
and lung cancer (Ptrend= .01) increased with increasing cumulative exposure to benzene.
Investigations continue to relate benzene exposure to specific lymphatic and hematopoietic
malignancies and other causes of death. Environ Health Perspect 104(Suppl 6):1349-1352 (1996)
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Introduction
Benzene is a solvent widely used in industry
and found in cigarette smoke, gasoline,
automobile emissions, and other products
(1). Benzene exposure has been related in
numerous occupational studies to increased
risk of acute nonlymphocytic leukemia
(ANNL) (2) and, in some reports, to other
lymphohematopoietic malignancies (3-5).
In 1981, the Chinese Academy of
Preventive Medicine (CAPM) carried out a
national occupational survey in which more
than 500,000 workers exposed to benzene
in China were identified (6). Subsequently,
28,460 of these exposed workers and
28,257 nonexposed workers were followed
for cancer mortality between 1972 and
1981 (7,8). Significantly elevated standard-
ized mortality ratios were noted among
exposed compared to nonexposed workers
for leukemia (standard mortality ratio
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[SMR] = 5.74) and lung cancer (SMR =
2.31), whereas elevated but nonsignificant
excesses were noted for cancers ofthe liver,
stomach, esophagus, intestine, nasophar-
ynx, and lymphosarcoma (8). Since 1987,
the U.S. National Cancer Institute (NCI)
has collaborated with the CAPM to expand
this study in cohort size, duration, recency
offollow-up, and exposure assessment.
Previously (9), we described the overall
risk for benzene-associated diseases in this
cohort, including excess risk for leukemia
and lymphoma among benzene-exposed
workers. In the current study we utilize
information on levels ofbenzene exposure
and report on the exposure-response
relationship with respect to benzene and
mortality risk.
Methods
The methods for this expanded study are
described in detail elsewhere (10,11). The
benzene-exposed group was comprised of
workers employed between 1972 and 1987
in 1427 selected benzene-exposed work
units (departments) in 672 factories in 12
cities in China. Workers in a variety of
industries and occupations that use ben-
zene were studied; the occupational areas
included painting, printing, and manufac-
ture offootwear, paint, and other chemi-
cals. A nonexposed comparison group was
assembled from workers employed between
1972 and 1987 in work units in which
benzene was not used in 69 ofthese facto-
ries or in 40 additional factories. Subjects
were identified from initial employment,
salary, and other factory records. We
abstracted demographic data, including
birth date, sex, and occupational data,
including the dates of employment by
work unit and job title for all jobs held by
subjects in the study factories. Benzene-
exposure jobs were determined from fac-
tory-level and job title-specific information
on benzene use.
For the cohort study, average occupa-
tional exposure to benzene (in ranges of< 1
ppm, 1-<5 ppm, 5-<10 ppm, 10-<25
ppm, 25-<50 ppm, and 50 + ppm) was
estimated by local industrial hygienists and
other industrial health personnel for seven
calendar periods (1949-1959, 1960-1964,
1965-1969, 1970-1974, 1975-1979,
1980-1984, 1985 and later) and for study-
specific job titles (11). A total of 18,435
job and calendar period-specific exposure
estimates were made, 38% based upon
monitoring data collected primarily after
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1975. When no monitoring data were
available or when the measurement results
were not consistent with other exposure
information (including amount of ben-
zene-containing materials, percent ofben-
zene in the materials, average frequency of
exposure, and changes in industrial hygiene
controls), monitoring data from other cal-
endar periods were used, with adjustment
for historical changes and exposure fre-
quency. If no monitoring data for the spe-
cific job were available in any calendar
period, monitoring results for similar jobs
were used after task descriptions and his-
torical changes were considered. Ifnone of
the above sources were available, the field
center staffused all available exposure infor-
mation and their professional judgment to
estimate the exposure.
Subjects were followed for selected
lymphohematopoietic malignancies and
other hematologic disorders and for vital
status to 31 December 1987. We used fac-
torypersonnel records at study factories and
subsequent places ofemployment or, when
necessary, contacted next-of-kin, work
colleagues, treating physicians, or others.
For deceased subjects, cause ofdeath was
obtained from medical records, other writ-
ten factory records, or death certificates.
Only after extensive search had failed to
locate written records listing cause ofdeath
were treating physicians or next-of-kin con-
tacted. For any worker suspected ofhaving
any hematopoietic or lymphoproliferative
malignancy or nonmalignant related disor-
der, extensive efforts were made to obtain
detailed medical records, hematological
laboratory reports, histopathology reports,
and pathology specimens. Details of the
specific information abstracted and the
review of clinicopathologic material by
expert U.S. and Chinese hematopatholgists
are described elsewhere (12,13).
For the statistical analysis, subjects
employed less than 6 months and those
hired before 1949 were excluded. Person-
years were accumulated for the benzene-
exposed workers, with a 1.5-year lag, from
1 January 1972 or, ifhired later, from the
first date of employment in a benzene-
exposed job until death, loss to follow-up,
or 31 December 1987. For the nonexposed
comparison group, person-years were accu-
mulated from 1 January 1972 or, ifhired
later, from the first date ofemployment.
Analyses ofmortalitywere made by internal
comparison ofdisease rates in the benzene-
exposed group to the rates in the unexposed
group, with adjustment by Poisson regres-
sion for age and sex as appropriate, yielding
relative risk (RR) for exposed versus non-
exposed workers (14,15). Tests for trend
of increasing risk with increasing level of
benzene exposure were carried out.
Results
The study group consisted of 74,828
benzene-exposed and 35,805 nonexposed
workers. On average, benzene-exposed sub-
jects were followed for 10.5 years, while
nonexposed subjects were followed for
11.7 years. Women contributed 47% of
the person-years in the benzene-exposed
study group and 40% in the nonexposed
group. Overall, the study groups were
young, with about 60% ofthe total person-
years at risk contributed by subjects less
than 30 years old at study entry. In this
young study population, about 2% died
during the follow-up period (1,369 ben-
zene-exposed and 598 nonexposed). Only
147 exposed (0.20%) and 90 unexposed
(0.25%) workers were lost to follow-up.
As shown in Table 1, all-cause mortal-
ity is slightly increased among workers
with greater cumulative exposure to ben-
zene (Pftend<0.05), but this excess is largely
due to cancer deaths (Ptrend<0.01). In gen-
eral, other nonmalignant causes of death
were not related to cumulative benzene
exposure except for occupational injuries.
Deaths due to all hematopoietic and
lymphoproliferative malignancies (HLM)
(Pfr,dJ= 0.01) and lung cancer (pt,d= 0.01)
were increased among workers with greater
cumulative exposure to benzene (Table 2).
Other cancer sites showing suggestive but
not statistically significant excesses include
nasopharynx and esophagus.
Discussion
We found increased mortality due to
lymphatic and hematopoietic malignancies,
lung cancer, and occupational injuries
in association with increased exposure to
benzene. Suggestive associations were
noted for other causes ofdeath, including
nasopharyngeal and esophageal cancer.
Because ofthe known relationship ofben-
zene as a risk factor for ANNL and prelim-
inary evidence from this and other studies
implicating benzene in the etiology of
other HLMs (2-5), we are continuing
statistical evaluations ofthis association
In experimental studies (16,17) ben-
zene has been found to cause cancer at
Table 1. Mortalitya among Chinese workers, by cumulative benzene exposure.
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Table 2. Cancer mortality8 among Chinese workers, by cumulative benzene exposure.
Cause of death Cumulative exposure, ppm-years p-au
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multiple sites, suggesting that excesses of
hematological and nonhematological
tumors in humans could be causally related
to exposure. Lung cancer mortality showed
an exposure-response pattern in our study.
Benzene exposure has not previously been
related to lung cancer (2) except for an ear-
lier report from a subset of the present
cohort (8). In that report an overall excess
was shown in a comparison of ever- and
never-exposed workers (SMR = 2.3), but no
evaluation oflevel ofbenzene exposure was
made. In the current study, however, we
show that the excess risk parallels increases
in cumulative benzene exposure. Some ben-
zene-exposed workers in this cohort were
employed in occupations that have previ-
ously been associated with increased lung
cancer risk; these workers include painters
(18) and leather workers (19). We plan
further studies to determine if the associa-
tion ofbenzene with lung cancer risk is due
specifically to benzene or to other types of
exposure, including tobacco use.
Suggestive increases in risk were seen
for nasopharyngeal and esophageal cancer.
Continued monitoring will provide oppor-
tunities to study these associations in more
detail as additional tumors are identified in
the aging study cohort. Excess mortality
was also found due to industrial accidents
amongworkers highly exposed to benzene.
A limited number of epidemiologic
investigations have provided the scientific
base for determining the quantitative rela-
tionship between benzene exposure and
cancer risk (20-22). Because we have char-
acterized exposure in detail for a large num-
ber ofbenzene-exposed men and women,
data from this cohort should provide a
substantive addition to current knowledge.
The study had several additional
strengths. Although the present analysis is
limited to mortality outcomes, cases of
lymphatic and hematopoietic diseases have
been identified and classified by disease
type following review of available patho-
logic material and medical records (12,13).
This detailed information will be utilized
in future reports. Quantitative exposure
estimates have been developed for cohort
study subjects (11) and these estimates cor-
relate with the occurrence of benzene
hematotoxicity (23), supporting the valid-
ity ofour approach to exposure estimation.
Complementary to these investigations,
biomarker studies among a series ofworkers
with current benzene exposure and among
workers with a history of benzene toxicity
are being analyzed to provide insight into
mechanisms ofbenzene-associated disease
in humans (24).
Several limitations should also be
noted. Detailed evaluation of more than
110,000 study subjects necessitated a large
number of investigators at many sites,
requiring extensive efforts at study coordi-
nation. Although not unique to this study,
exposure assessment relied upon limited
measurement data, particularly for the
early years ofstudy. Efforts are continuing
to refine and validate these estimates. The
cohort is young and follow-up continues to
characterize further the long-term effects of
benzene exposure as the cohort ages.
In summary, mortality due to lymphatic
and hematopoietic malignancies, lung
cancer, and occupational accidents increased
in direct relation to cumulative benzene
exposure among industrial workers in
China. The results are preliminary; further
investigations are planned to characterize
the scope ofbenzene as a human carcinogen
in this large cohort ofindustrial workers.
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